Skip to content
2000
Volume 10, Issue 18
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Aminoglycosides are important broad-spectrum antibiotics used in the therapy of many microbial infections. As the bacterial resistance to antibiotic therapy is appearing as an increasingly significant threat to public health, the development of aminoglycoside antibiotics with extended antibacterial spectrum and potency, devoid of nephro- and ototoxicity, and evading the resistance process returns to the focus of researchers. In this review, various developments brought to the aminoglycoside family of antibiotics effective against resistant bacteria have been described, focused on chemical modifications, drug-modifying enzyme inhibitors, and conformationally constrained analogs, as well as related antibacterial compounds, with the hope to provide information useful in rational design of novel antibiotics addressing bacterial resistance, and paving the way for new perspectives in antimicrobial therapy.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/156802610793176684
2010-12-01
2025-09-15
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/156802610793176684
Loading

  • Article Type:
    Research Article
Keyword(s): 16S rRNA; 2-deoxystreptamine; 3,5-diamino-piperidinyl triazines; 5-deoxy-5-epiamino-ABK; 5-deoxy-5-episubstituted arbekacin derivatives; acetyl coenzyme A; acetyltrans-ferases; acetyltransferases; adenyltransferases; aminocyclitol; Aminoglycoside; Aminoglycoside 3'-phosphotransferases; aminoglycoside 3'-phosphotransferases; Aminoglycoside antibiotics; aminoglycoside-modifying; aminoglycoside-modifying enzyme; aminoglycoside-resistant bacteria; ANT (2'') Inhibitors; anti-anthrax drugs; Anti-APH(2'')/AAC(6'); Anti-APH(3')s; antimicrobial activity; antimicrobial therapy; APH Inhibitors; Arbekacin; bacterial resistance; bovine antimicrobial peptide indolicidin; broad-spectrum antibiotics; C16 or C20 fatty acid; Cipro-NeoB hybrids; dibekacin; Dimeric Derivatives; DNA gyrase; drug-modifying enzymes; fluoroquinolone- ciprofloxacin; gentamicins; glycosidic linkage; Gram-negative; Gram-negative APH(3'); Gram-positive; Hoog-steen face; hydroxyamine motif; inhibitor; kanamycins; methicillin-resistant Staphylococcus aureus; multidrug resistant; Mycobacterium tuberculosis; N-acetyltransfer; neamine dimers; Neamine-derived pseudodisaccharides; neomycin; neomycin B; netilmicin; Non-Carbohydrate Inhibitors of AGMEs; nucleo-tidyltransferases; nucleophilic amino acid side chain; O-acetyltransfer; Ototoxicity; pa-ramomycin; paromomycin; phosphotransferases; protein kinases; pSF815 plasmid; pyrophosphate group; resistance nodulation division; ribostamycin and pyranmycin; semi-synthetic derivatives amikamycin; sisomicin; spectinomycin; streptidine ring; structure-activity relationships; sulfotransferases; synthetic AAC(6') in-hibitors; tetraazidoneamine; tobramycin; topoisomerase; vancomycin-resistant enterococci; X-ray crystallography
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test